Chemoinformaics analysis of ALPHA-NEPETALACTONE
| Molecular Weight | 166.22 | nRot | 0 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 11 |
| Exact Molecular Weight | 166.099 | nRing | 2 |
| Solubility: LogS | -1.924 | nHRing | 1 |
| Solubility: LogP | 2.334 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 27.6391 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.515 |
| Synth | 4.123 |
| Natural Product Likeliness | 2.706 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.005 |
| CACO-2 | -4.457 |
| MDCK | 0.0000193 |
| BBB | 0.996 |
| PPB | 0.306856 |
| VDSS | 1.015 |
| FU | 0.73128 |
| CYP1A2-inh | 0.512 |
| CYP1A2-sub | 0.453 |
| CYP2c19-inh | 0.178 |
| CYP2c19-sub | 0.858 |
| CYP2c9-inh | 0.048 |
| CYP2c9-sub | 0.194 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.351 |
| CYP3a4-inh | 0.142 |
| CYP3a4-sub | 0.458 |
| CL | 8.369 |
| T12 | 0.622 |
| hERG | 0.018 |
| Ames | 0.011 |
| ROA | 0.072 |
| SkinSen | 0.906 |
| Carcinogencity | 0.939 |
| EI | 0.839 |
| Respiratory | 0.534 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.918926 |